Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Introducing FactsR by Corti — the First Clinical Reasoning Layer for Ambient AI in Healthcare
Real-time, recursive, fact-first architecture reduces AI-generated "note bloat" by 65 percent and…
cBrain appoints new CFO
Company Announcement no. 07/2025 cBrain appoints new CFO Copenhagen, June 11, 2025…
Carlsberg lays on the perfect ride to surprise taxi drivers during the UEFA Nations League Finals 2025
9 in 10 taxi drivers consider themselves football fans, yet 91% have…
The Brain Prize: HM The King of Denmark presents prestigious prize to US and German scientists for seminal discoveries in brain cancer
Two pioneering scientists received The Brain Prize 2025 for their discoveries that…